AMANDA SANCHEZ: Open Payments
NPI 1891773990 · SUMMERVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$713 in 35 payments from 13 companies in 2025. Trend: 2023 $1,244 · 2024 $1,020 · 2025 $713
Food & beverage: $713
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $179 |
| Lilly USA, LLC | 5 | $113 |
| Novo Nordisk Inc | 4 | $76 |
| SHIELD THERAPEUTICS INC | 3 | $54 |
| Amgen Inc. | 2 | $46 |
| SANOFI-AVENTIS U.S. LLC | 2 | $43 |
| Exact Sciences Corporation | 2 | $38 |
| Medtronic, Inc. | 2 | $33 |
| Edwards Lifesciences Corporation | 1 | $31 |
| Vanda Pharmaceuticals Inc. | 1 | $30 |
Products named: VRAYLAR, MOUNJARO, UBRELVY, ACCRUFER, TZIELD, Ozempic, INTELLIS ADAPTIVESTIM, SAPIEN 3 Ultra RESILIA.
Industry payments across SC — which companies pay providers there.
